Pharmaessentia Corp (6446 TT)

124

Analysis

Health Care • Taiwan

PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.

Refresh

Company Presentation • 25 Aug 2026 15:45

PharmaEssentia Corp.

Company Presentation • 12 Aug 2026 13:30

Q2 2026

Company Presentation • 12 Aug 2026 14:30

PharmaEssentia Corp.

Company Presentation • 14 May 2026 14:30

PharmaEssentia Corp.

Company Presentation • 03 Mar 2026 14:30

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00